Boehringer headquarters, “It is right we notified the cancellation at 7:06pm on 29th”

When it comes to the Hanmi Pharm’s technology export agreement cancellation, the opposite party of the cancellation, Boehringer Ingelheim, has released an official position.

According to a report on the 6th, Boehringer Ingelheim announced it did not have any discussion about the cancellation of the ‘Olita(generic name: olmutinib)’ agreement with Hanmi Pharm. It also confirmed the date of the n...